Related Experiment Videos
BRCA1 participates in DNA decatenation
Zhenkun Lou1, Katherine Minter-Dykhouse, Junjie Chen
1Department of Oncology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
Nature Structural & Molecular Biology
|June 21, 2005
Summary
The tumor suppressor BRCA1 is crucial for genomic stability. This study reveals BRCA1
Area of Science:
- Cell Biology
- Genetics
- Molecular Biology
Background:
- The BRCA1 tumor suppressor is known for its role in genomic stability, particularly in DNA repair and cell cycle checkpoints after DNA damage.
- Its function in normal cells, without DNA damage, remains less understood.
Purpose of the Study:
- To investigate the normal function of BRCA1 in maintaining genomic stability, specifically its role in DNA decatenation and chromosome segregation.
- To explore the relationship between BRCA1 and topoisomerase IIalpha.
Main Methods:
- Immunofluorescence microscopy to observe BRCA1 and topoisomerase IIalpha colocalization in S phase cells.
- Analysis of chromosome segregation in BRCA1-deficient cells and cells treated with a topoisomerase IIalpha inhibitor (ICRF-193).
- In vitro DNA decatenation assays using extracts from BRCA1-deficient cells.
- Western blotting to assess topoisomerase IIalpha ubiquitination.
Main Results:
- BRCA1 interacts and colocalizes with topoisomerase IIalpha in S phase cells.
- BRCA1-deficient cells exhibit chromosome lagging, indicative of defective DNA decatenation and segregation, similar to cells treated with ICRF-193.
- BRCA1 deficiency impairs DNA decatenation activity in vitro.
- Topoisomerase IIalpha ubiquitination is dependent on BRCA1 and correlates with increased DNA decatenation activity.
Conclusions:
- BRCA1 plays a significant role in DNA decatenation, a process essential for chromosome segregation.
- This study uncovers a novel function of BRCA1 in maintaining genomic stability through its regulation of topoisomerase IIalpha activity.